Grace Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Grace Capital's PFE Position: Q4 2021 in Review
Grace Capital increased its Pfizer (PFE) stake by 38% in Q4 2021, buying an estimated $197K and bringing the position to 14,552 shares worth $859K. The position accounts for 0.51% of the portfolio, ranked #55.
Grace Capital first reported a position in PFE in Q2 2017 and has held it in 19 quarters since. The position peaked at $5.66M in Q4 2018. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- Grace Capital held 14,552 shares of Pfizer worth $859K as of Q4 2021.
- Grace Capital bought 3,980 Pfizer shares in Q4 2021, an estimated $197K.
- Pfizer made up 0.51% of Grace Capital's portfolio in Q4 2021, its #55 holding.
- Grace Capital first reported a position in Pfizer in Q2 2017 and has held it in 19 quarters since.
- Grace Capital's Pfizer position peaked at $5.66M in Q4 2018.
- 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.